Please ensure Javascript is enabled for purposes of website accessibility

The Most Likely Reason Charlotte's Web Holdings Stock Dropped 10.9% Today

By Keith Speights - Updated Oct 1, 2019 at 6:41PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

An ebbing tide lowers all boats.

What happened

Shares of Charlotte's Web Holdings (CWBHF -3.57%) dropped 10.9% on Tuesday. The hemp cannabidiol (CBD) leader didn't announce any negative news. Instead, it appears that Charlotte's Web simply felt the brunt of an overall market sell-off, perhaps intensified because of continued pressure on cannabis stocks in general.

There's also another factor to consider. Charlotte's Web archrival CV Sciences (CVSI -1.59%) reported good news today with a deal with Harris Teeter. CV Sciences' PlusCBD Oil products will be distributed in 150 Harris Teeter locations across five states. CV Sciences stock jumped more than 15% on the news.

Cannabis plant with CBD chemical structure

Image source: Getty Images.

So what

What does all of this mean for long-term investors? Nothing. Absolutely nothing.

It's not surprising in the least that Charlotte's Web stock would fall harder than the overall market on the worst day for the S&P 500 index in six weeks. That's especially the case considering the general malaise for cannabis stocks, particularly with concerns in the U.S. about health problems related to vaping cannabis products.

But volatility is a fact of life with investing in cannabis stocks. Just as stocks like Charlotte's Web can experience steeper declines than the broader market, they can also enjoy bigger upswings.

What about the impact of CV Sciences' deal with Harris Teeter? It really doesn't impact Charlotte's Web materially. Although the Harris Teeter agreement pushes the number of retail stores carrying CV Sciences' products to more than 5,400 locations across the U.S., Charlotte's Web's store count is well above 8,000. And the company recently scored an even bigger deal of its own, announcing that The Vitamin Shoppe has started selling its CBD gummies in 738 stores across 45 states.

Now what

The best thing that investors can do is ignore the noise of stock fluctuations and focus on Charlotte's Web's execution on its business strategy. The company has significantly increased its production capacity in anticipation of greater sales in the future as the U.S. CBD market grows. Charlotte's Web also continues to make great strides in expanding its retail distribution network, as the recent deal with The Vitamin Shoppe shows.

Investors should also monitor the Food and Drug Administration's progress with establishing CBD regulations. Charlotte's Web's prospects could vary considerably based on what the FDA decides.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends Charlotte's Web. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Charlotte's Web Holdings, Inc. Stock Quote
Charlotte's Web Holdings, Inc.
$0.65 (-3.57%) $0.02
Vitamin Shoppe, Inc. Stock Quote
Vitamin Shoppe, Inc.
CV Sciences, Inc. Stock Quote
CV Sciences, Inc.
$0.03 (-1.59%) $0.00

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/08/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.